Contact
C18:0 DG-PEG2K-triGalNAc

C18:0 DG-PEG2K-triGalNAc A88258 (Previously 880258) 1,2-Dioctadecyl-sn-glycero-3N-[carboxy(polyethylene glycol)-2000]-N-tri(N-acetylgalactosamine)

C18:0 DG-PEG2K-triGalNAc

C18:0 DG-PEG2K-triGalNAc is a functionalized PEG lipid that enhances targeted drug delivery by binding to the Asialoglycoprotein Receptor (ASGPR) which are predominantly found on the surface of liver cells. By functionalizing C18:0 DG-PEG2K with triGalNac, it allows this PEG lipid to be used in the formation of liposomes or LNPs that target the liver for drug delivery.

Patent pending.  Application No. 63/776,541

00000000
$0.00
Buy
Please confirm your location

Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate location button below.

For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!

*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada